IRX Therapeutics reports positive IRX-2 phase 2a head and neck squamous cell carcinoma clinical results Read more
Alcami Announces Grand Opening of St. Louis, Missouri Facility in Cortex Innovation Community Read more
Bioverativ, Bicycle Therapeutics to develop therapies for hemophilia and sickle cell disease Read more
Midatech submits MTD201 CTA filing for first in human study in carcinoid cancer and acromegaly Read more
Alcami to Establish Active Pharmaceutical Ingredient Center of Excellence in Germantown, Wisconsin Read more